Results 101 to 110 of about 4,177,143 (225)

Overview of the Japanese Rapid Introduction Premium as a drug pricing framework to enhance patient access to innovative drugs. [PDF]

Health Econ Rev
Takamura K, Jinnai G, Niwa Y, Kondoh M.
europepmc   +1 more source

Antibiotic Use Thresholds for Carbapenem-Resistant Gram-Negative Bacteria: A Nonlinear Time-Series Study. [PDF]

Infect Drug Resist
Sun C, Qian F, Luo Q, Chen C, Wang S, Yu J.   +5 more
europepmc   +1 more source

Uncovering molecular determinants of potency and binding affinity in hit compounds targeting FGF14/Nav1.6 complex. [PDF]

J Cheminform
Teimouri H, Haghighijoo Z, Baumgartner TJ, Singh AK, Wadsworth PA, Zhang C, Chen H, Zhou J, Laezza F.   +8 more
europepmc   +1 more source

Current Status of Drug Lag in Rare Disease Treatment and a Multifaceted Approach to Resolving It

Kota Kodama
openalex   +2 more sources

An overview of recent advancements in targeted cancer therapies and their potential clinical impact. [PDF]

RSC Med Chem
Ahmed S, Sakla AP, Jahan K, Neshat N, Akhter M, Aaghaz S, Kamal A.   +6 more
europepmc   +1 more source

A novel folate receptor-targeted curcumin nano-delivery system: A dual therapeutic strategy for precise inhibition of MRCKβ to suppress ovarian cancer proliferation and immune escape. [PDF]

Mater Today Bio
Shi M, Chen L, Yu Y, Wang H, Zhang MJ.
europepmc   +1 more source

Chronomodulated press-coated pulsatile therapeutic system for aceclofenac: optimization of factors influencing drug release and lag time

, 2011
Sumit Patil, Swati Pund, Joshi, Aliasgar Shahiwala, Shishoo   +4 more
openalex   +2 more sources

A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens. [PDF]

J Antimicrob Chemother
Dickinson L, Else L, Venter WDF, Boffito M, Brand R, Waitt C, Hill A, Khoo S.   +7 more
europepmc   +1 more source

Additional file 1 of Trends, lag and characteristics of rare disease drug approval in the USA and China, 1983–2022

Shaohong Wang, Xin Liu, Yuzhen Zou, Yan Tang, Wei Zuo, Rong Jiang, Junmei Shang, X Tian, Q P Liu, Tingting Xu, Bo Zhang, Shuyang Zhang   +11 more
openalex   +1 more source

A Guide to Time lag and Time lag Shortening Strategies in Oncology-Based Drug Development

, 2017
Berna Uygur, Josh Duberman, Steven M. Ferguson   +2 more
openalex   +1 more source